Bingmei Dong

Prof. Bingmei Dong


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2023 in Veterinary Microbiology
Verified
Journal Article
Closed access
BDBingmei Dong
Bingmei Dong
FLFeng Li
Feng Li
JWJinliang Wang
Jinliang Wang
SLSufang Lv
Sufang Lv
LMLizhong Miao
Lizhong Miao
ZSZhiqiang Shen
Zhiqiang Shen

30 January 2022 in Journal of Virological Methods
Verified
Journal Article
Closed access
BDBingmei Dong
Bingmei Dong
NTNa Tang
Na Tang
YGYu Guan
Yu Guan
GQGuanggang Qu
Guanggang Qu
LMLizhong Miao
Lizhong Miao
SZShen Zhiqiang
Shen Zhiqiang

31 December 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
BDBingmei Dong
Bingmei Dong
RWRuonan Wang
Ruonan Wang
YGYu Guan
Yu Guan
XZXiubao Zhao
Xiubao Zhao
RLRonghua Li
Ronghua Li
NTNa Tang
Na Tang
Background: Large-scale production of poultry viral vaccines increasingly requires robust suspension cell platforms. However, most avian cell lines, including DF-1, are strictly anchorage-dependent, limiting scalability. Aquaporin-1 (AQP1) regulates cell–cell adhesion and membrane dynamics, making it a potential target for engineering suspension growth. This study aimed to generate a stable DF-1 suspension cell line via AQP1 disruption and evaluate its potential for enhanced infectious bursal disease virus (IBDV) production. Methodology: DF-1 cells were engineered using a CRISPR/Cas9 ribonucleoprotein system to create a truncated AQP1 gene. DF-1/AQP1− cells were assessed for morphology, tumorigenicity in nude mice, and genetic stability across 20 passages. Suspension growth, cell density, and viability were measured. Cells were infected with IBDV strain BJQ902, and viral titers were compared with wild-type DF-1 and monolayer DF-1/AQP1− cells. Results: DF-1/AQP1− cells maintained normal morphology, were non-tumorigenic, and retained stable AQP1 mutations. They grew as true suspension cultures without adaptation, reaching 4.0 × 106 cells/mL with >95% viability. Suspension DF-1/AQP1− cells cells produced significantly higher viral titers (9.0 log TCID50/mL; 8.63 log EID50/mL) than both monolayer DF-1/AQP1− and wild-type DF-1 cells. Virus production time was shortened in suspension cultures. Conclusions: Targeted AQP1 disruption converts DF-1 cells into a stable, non-tumorigenic suspension cell line with markedly enhanced IBDV production, providing a scalable platform for next-generation avian vaccine manufacturing.